Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 3
1999 3
2000 2
2001 6
2002 8
2003 8
2004 7
2005 17
2006 15
2007 11
2008 13
2009 23
2010 26
2011 22
2012 14
2013 14
2014 11
2015 6
2016 7
2017 11
2018 16
2019 11
2020 13
2021 9
2022 9
2023 8
2024 14
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
Storage proteins.
Fujiwara T, Nambara E, Yamagishi K, Goto DB, Naito S. Fujiwara T, et al. Among authors: goto db. Arabidopsis Book. 2002;1:e0020. doi: 10.1199/tab.0020. Epub 2002 Sep 30. Arabidopsis Book. 2002. PMID: 22303197 Free PMC article.
[Adalimumab].
Goto D, Sumida T. Goto D, et al. Nihon Rinsho. 2002 Dec;60(12):2384-9. Nihon Rinsho. 2002. PMID: 12510366 Review. Japanese.
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, Hasegawa M, Matsushita T, Saito K, Motegi SI, Yoshifuji H, Yoshizaki A, Kohmoto T, Takagi K, Oka A, Kanda M, Tanaka Y, Ito Y, Nakano K, Kasamatsu H, Utsunomiya A, Sekiguchi A, Niiro H, Jinnin M, Makino K, Makino T, Ihn H, Yamamoto M, Suzuki C, Takahashi H, Nishida E, Morita A, Yamamoto T, Fujimoto M, Kondo Y, Goto D, Sumida T, Ayuzawa N, Yanagida H, Horita T, Atsumi T, Endo H, Shima Y, Kumanogoh A, Hirata J, Otomo N, Suetsugu H, Koike Y, Tomizuka K, Yoshino S, Liu X, Ito S, Hikino K, Suzuki A, Momozawa Y, Ikegawa S, Tanaka Y, Ishikawa O, Takehara K, Torii T, Sato S, Okada Y, Mimori T, Matsuda F, Matsuda K, Amariuta T, Imoto I, Matsuo K, Kuwana M, Kawaguchi Y, Ohmura K, Terao C. Ishikawa Y, et al. Among authors: goto d. Nat Commun. 2024 Jan 31;15(1):319. doi: 10.1038/s41467-023-44541-z. Nat Commun. 2024. PMID: 38296975 Free PMC article.
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer.
Miyake M, Owari T, Iida K, Onishi S, Nishimura N, Fujii T, Jinno CN, Furuya H, Oda Y, Miyamoto T, Tomizawa M, Shimizu T, Onishi K, Hori S, Morizawa Y, Goto D, Nakai Y, Tanaka N, Miura N, Kikugawa T, Saika T, Rosser C, Fujimoto K. Miyake M, et al. Among authors: goto d. Cancer Chemother Pharmacol. 2025 Jun 25;95(1):62. doi: 10.1007/s00280-025-04783-8. Cancer Chemother Pharmacol. 2025. PMID: 40560260
Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
Hamaguchi Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, Miyamae T, Ishikawa H, Ae R, Nakamura Y, Asano Y, Fujimoto M; Ministry of Health, Labour and Welfare's Localized Scleroderma Research Group. Hamaguchi Y, et al. J Dermatol. 2025 May;52(5):860-871. doi: 10.1111/1346-8138.17684. Epub 2025 Mar 5. J Dermatol. 2025. PMID: 40040588
Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.
Uesugi-Uchida S, Fujimoto M, Asano Y, Endo H, Goto D, Jinnin M, Kawaguchi Y, Tanaka S, Tokunaga T, Makino K, Matsushita T, Motegi SI, Yoshizaki A, Sato S, Hasegawa M. Uesugi-Uchida S, et al. Among authors: goto d. J Dermatol. 2024 Oct;51(10):1290-1297. doi: 10.1111/1346-8138.17403. Epub 2024 Sep 5. J Dermatol. 2024. PMID: 39235167 Free PMC article.
290 results